Preparation and characterization of a purified influenza virus neuraminidase vaccine

By Hocart M.   Grajower B.   Donabedian A.   Pokorny B.   Whitaker C.   Kilbourne E.D.  

Vaccine, Vol. 13, Iss. 18, 1995-01 ,pp. : 1793-1798

Elsevier

Access to resources Recommend Favorite

Cross-protection against a lethal influenza virus infection by DNA vaccine to neuraminidase

By Chen Z.   Kadowaki S.-E.   Hagiwara Y.   Yoshikawa T.   Matsuo K.   Kurata T.   Tamura S.-I.  

Vaccine, Vol. 18, Iss. 28, 2000-08 ,pp. : 3214-3222

Elsevier

Access to resources Recommend Favorite

Epidermal powder immunization using non-toxic bacterial enterotoxin adjuvants with influenza vaccine augments protective immunity

By Chen D.   Endres R.L.   Erickson C.A.   Maa Y.-F.   Payne L.G.  

Vaccine, Vol. 20, Iss. 21, 2002-06 ,pp. : 2671-2679

Elsevier

Access to resources Recommend Favorite

Immunogenicity of influenza A virus N2 neuraminidase produced in insect larvae by baculovirus recombinants

By Johansson B.E.   Price P.M.   Kilbourne E.D.  

Vaccine, Vol. 13, Iss. 9, 1995-06 ,pp. : 841-845

Elsevier

Access to resources Recommend Favorite

Supplementation of conventional influenza A vaccine with purified viral neuraminidase results in a balanced and broadened immune response

By Johansson B.E.   Matthews J.T.   Kilbourne E.D.  

Vaccine, Vol. 16, Iss. 9, 1998-05 ,pp. : 1009-1015

Elsevier

Access to resources Recommend Favorite